This AI Model Designs Enzymes With Atomic Precision
Researchers at the University of Washington have developed AI-designed enzymes capable of cutting proteins associated with diseases like Alzheimer's. The lab also introduced RFdiffusion3, a generative AI model that designs proteins at the atomic level.
Why it matters
This advancement in protein engineering could lead to breakthrough medications for previously 'undruggable' diseases and represents a major leap in synthetic biology.
The protein universe is about to get bigger.Scientists can now use AI to build proteins never before seen in nature. These designer proteins may become therapeutics, environmental sensors, or even the building blocks of synthetic life.Despite enormous potential, however, AI tools still struggle to design complex proteins, like enzymes, from scratch. Unlike small proteins or peptide binders that disrupt cellular signaling, enzymes are shape shifters with a catalytic core. Getting the right shape is only half of the battle. The components must also quickly move, align, and interact at just the right moment.But effective AI-designed enzymes may be here soon. This month, Nobel laureate David Baker’s lab at the University of Washington unveiled two types of AI-designed proteases. Proteases are like molecular scissors that cut other proteins at specific sites.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in